Several actionable cancer genes such as EGFR, ALK, ROS1, BRAF have been identified, for which specific targeted therapies exist; however, >40% of patients’ tumors do not have alterations in actionable genes thus excluding for these patients the possibility of being treated with a targeted therapy (Chan and Hughes, 2015). Here, BRAF is linked to cancer.